Clinical Trial

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-05-21; most recent amendment 2026-04-28.
Status change: Recruiting → Active, Not Recruiting 2025-03-31
Status change: Not Yet Recruiting → Recruiting 2022-12-15
Trial Details
NCT Number NCT04403139
Lead Sponsor University of Washington
Collaborators: National Institute on Aging (NIA)
Conditions Varicella Zoster Virus Infection
Enrollment 50 participants
Start Date 2022-04-27
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-05